Medical Action Blood Culture Collection Kits
Blood culture collection kits contain an applicator with an open or incomplete seal that may compromise sterility and lead to infection.
Moderate risk
Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
Medical Action Industries, Inc., of Arden, North Carolina, began a recall on July 23, 2026, of Blood Culture Collection Venipuncture Kit 20/Cs, REF: 77451; Blood Culture Kit 20/Cs, REF: 81834B; and Blood Culture Collection Kit, REF: 81834C, all containing BD ChloraPrep Clear - 1 mL Applicators. The kits were distributed in Indiana, North Carolina, and Ohio.
The recall was added to the FDA's Enforcement Report and classified on September 16, 2026, and in the FDA's weekly enforcement report on September 23, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is your kit affected?
Affected if its UDI-DI is listed.
Blood Culture Collection Venipuncture Kit 20/Cs, REF: 77451; Blood Culture Kit 20/Cs, REF: 81834B; Blood Culture Collection Kit, REF: 81834C. All containing BD ChloraPrep Clear - 1 mL Applicators
- UDI-DI
- 20809160195069
- 20809160403324
- 20809160466602
Details
- Company began the recall
- Sold in
US Nationwide distribution in the states of Ohio, Indiana, North Carolina.
- Event ID
- 99628
- Recall No.
- Z-3181-2026
- Company
- Medical Action Industries, Inc. 306Arden, North Carolina
- Hazard
- Sterility failure
- Recall type
- Voluntary: Firm initiated
- Customers told by
- Letter
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
